Ultrasound-guided steroid injection and rehabilitation exercises to ease shoulder pain in women who have undergone surgery for breast cancer

Efficacy of ultrasound-guided corticosteroid injection combined with personalized rehabilitation in breast cancer women with subacromial pain syndrome: A pilot randomized clinical study

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN10358568

Enrollment

Registered

2022-10-04

Start date

2022-03-10

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subacromial pain syndrome without tendon lesions following surgery for breast cancer Cancer

Interventions

Enrolled participants will be randomly assigned by a computer-generated randomization process with a 1:1 allocation without blocks. Participants randomized to Group A will undergo an interdisciplinary

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Aged 18 years old and over 2. Female gender 3. Surgery for breast cancer 4. Subacromial pain syndrome 5. Numerical Pain Rating Scale (NPRS) > 5 6. Signed informed consent

Exclusion criteria

Exclusion criteria: 1. Allergies to triamcinolone or lidocaine 2. Severe thrombocytopenia (<10,000plt) or bleeding disorders 3. Chemotherapy or radiotherapy in progress 4. Metastatic disease 5. Shoulder tendon lesions 6. Cognitive impairment or psychiatric disorders 7. Pregnancy or breastfeeding

Design outcomes

Primary

Measure	Time frame
Pain measured using the Numerical Pain Rating Scale at baseline (T0), after 1 week (T1), and after three months of follow-up (T2)	—

Secondary

Measure	Time frame
1. Isometric muscle strength measured using the Hand Grip Strength test (HGS) (Jamar hydraulic hand dynamometer Sammons Preston, Rolyon, Bolingbrook, IL, USA) at baseline (T0), after 1 week (T1), and after three months of follow-up (T2) 2. Shoulder function measured using the Oxford Shoulder Score (OSS) at baseline (T0), after 1 week (T1), and after three months of follow-up (T2) 3. Quality of Life measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ - C30) at baseline (T0), after 1 week (T1), and after three months of follow-up (T2) 4. Patient satisfaction measured using the Global Perceived Effect (GPE) scale, after 1 week (T1), and after three months of follow-up (T2) 5. Safety measured using registering minor and major adverse events during the study period	—

Measure

Time frame

1. Isometric muscle strength measured using the Hand Grip Strength test (HGS) (Jamar hydraulic hand dynamometer Sammons Preston, Rolyon, Bolingbrook, IL, USA) at baseline (T0), after 1 week (T1), and after three months of follow-up (T2) 2. Shoulder function measured using the Oxford Shoulder Score (OSS) at baseline (T0), after 1 week (T1), and after three months of follow-up (T2) 3. Quality of Life measured using the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ - C30) at baseline (T0), after 1 week (T1), and after three months of follow-up (T2) 4. Patient satisfaction measured using the Global Perceived Effect (GPE) scale, after 1 week (T1), and after three months of follow-up (T2) 5. Safety measured using registering minor and major adverse events during the study period

—

Countries

Italy

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026